Lynne A. Wolfe

7.0k total citations · 1 hit paper
49 papers, 1.1k citations indexed

About

Lynne A. Wolfe is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Lynne A. Wolfe has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 13 papers in Genetics and 9 papers in Clinical Biochemistry. Recurrent topics in Lynne A. Wolfe's work include Glycosylation and Glycoproteins Research (12 papers), Metabolism and Genetic Disorders (9 papers) and Genomics and Rare Diseases (8 papers). Lynne A. Wolfe is often cited by papers focused on Glycosylation and Glycoproteins Research (12 papers), Metabolism and Genetic Disorders (9 papers) and Genomics and Rare Diseases (8 papers). Lynne A. Wolfe collaborates with scholars based in United States, Canada and United Kingdom. Lynne A. Wolfe's co-authors include Amy Goldstein, William A. Gahl, Gregory M. Enns, Thomas C. Markello, Andrea Gropman, Marni J. Falk, Philip G. Morgan, Sumit Parikh, Carol L. Greene and Mary Kay Koenig and has published in prestigious journals such as Journal of Clinical Investigation, Neurology and PEDIATRICS.

In The Last Decade

Lynne A. Wolfe

48 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society

2014 372 citations Sumit Parikh, Amy Goldstein et al. Genetics in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynne A. Wolfe United States	15	742	297	264	120	90	49	1.1k
Zuhair N. Al‐Hassnan Saudi Arabia	18	549 0.7×	291 1.0×	248 0.9×	166 1.4×	105 1.2×	78	1.0k
Brendan C. Lanpher United States	17	581 0.8×	259 0.9×	465 1.8×	109 0.9×	70 0.8×	41	1.2k
Faiqa Imtiaz Saudi Arabia	17	601 0.8×	139 0.5×	398 1.5×	131 1.1×	70 0.8×	74	1.1k
Shlomo Almashanu Israel	16	390 0.5×	271 0.9×	136 0.5×	128 1.1×	63 0.7×	45	838
Tomáš Honzík Czechia	23	1.1k 1.5×	524 1.8×	225 0.9×	233 1.9×	90 1.0×	102	1.6k
Robert D. S. Pitceathly United Kingdom	25	1.2k 1.6×	600 2.0×	124 0.5×	139 1.2×	61 0.7×	75	1.6k
Shoji Yano United States	17	386 0.5×	269 0.9×	162 0.6×	166 1.4×	37 0.4×	57	858
Luísa Diogo Portugal	20	790 1.1×	622 2.1×	304 1.2×	185 1.5×	74 0.8×	71	1.4k
Ali Dursun Türkiye	17	434 0.6×	438 1.5×	145 0.5×	215 1.8×	109 1.2×	97	995
David Coman Australia	20	583 0.8×	302 1.0×	227 0.9×	302 2.5×	51 0.6×	79	1.2k

Countries citing papers authored by Lynne A. Wolfe

Since Specialization

Citations

This map shows the geographic impact of Lynne A. Wolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne A. Wolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne A. Wolfe more than expected).

Fields of papers citing papers by Lynne A. Wolfe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne A. Wolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne A. Wolfe. The network helps show where Lynne A. Wolfe may publish in the future.

Co-authorship network of co-authors of Lynne A. Wolfe

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne A. Wolfe. A scholar is included among the top collaborators of Lynne A. Wolfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne A. Wolfe. Lynne A. Wolfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hall, Patricia, Christina Lam, Lynne A. Wolfe, & Andrew C. Edmondson. (2025). Biochemical testing for congenital disorders of glycosylation: A technical standard of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 27(4). 101328–101328. 1 indexed citations

Lam, Christina, et al.. (2024). Neurodevelopmental profiles of 14 individuals with phosphomannomutase deficiency (PMM2‐CDG). Journal of Inherited Metabolic Disease. 48(1). e12782–e12782. 1 indexed citations

Dang, An, Irene J. Chang, Lynne A. Wolfe, et al.. (2023). Elevated oxysterol and N‐palmitoyl‐O‐phosphocholineserine levels in congenital disorders of glycosylation. Journal of Inherited Metabolic Disease. 46(2). 326–334. 4 indexed citations

Macnamara, Ellen F., Yvonne L. Latour, Precilla D’Souza, et al.. (2023). Risks and benefits of anesthesia for combined pediatric procedures in the NIH undiagnosed diseases program. Molecular Genetics and Metabolism. 140(3). 107707–107707. 1 indexed citations

Montaño, Carolina, Shira G. Ziegler, Manfred Boehm, et al.. (2022). Diagnosis and discovery: Insights from the NIH Undiagnosed Diseases Program. Journal of Inherited Metabolic Disease. 45(5). 907–918. 4 indexed citations

Malicdan, May Christine V., Ellen F. Macnamara, Tanya Lehky, et al.. (2022). MYH2-associated myopathy caused by a novel splice-site variant. Neuromuscular Disorders. 33(3). 257–262. 3 indexed citations

Hong, Rui, Sheng-Yong Niu, Lynne A. Wolfe, et al.. (2021). FOXR1 regulates stress response pathways and is necessary for proper brain development. PLoS Genetics. 17(11). e1009854–e1009854. 5 indexed citations

Burke, Elizabeth A., Lynne A. Wolfe, Brian P. Brooks, et al.. (2020). A novel frameshift mutation in SOX10 causes Waardenburg syndrome with peripheral demyelinating neuropathy, visual impairment and the absence of Hirschsprung disease. American Journal of Medical Genetics Part A. 182(5). 1278–1283. 7 indexed citations

Mashimo, Masato, Xiangning Bu, Kazumasa Aoyama, et al.. (2019). PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells. JCI Insight. 4(4). 39 indexed citations

10.

Mulkey, Sarah B., Bobby G. Ng, Gilbert Vézina, et al.. (2018). Arrest of Fetal Brain Development in ALG11-Congenital Disorder of Glycosylation. Pediatric Neurology. 94. 64–69. 7 indexed citations

11.

Davids, Mariska, Megan Kane, Lynne A. Wolfe, et al.. (2018). Glycomics in rare diseases: from diagnosis tomechanism. Translational research. 206. 5–17. 5 indexed citations

12.

Toro, Camilo, Roderick Hori, May Christine V. Malicdan, et al.. (2017). A recurrent de novo missense mutation in UBTF causes developmental neuroregression. Human Molecular Genetics. 27(4). 691–705. 29 indexed citations

13.

Kane, Megan, Mariska Davids, David R. Adams, et al.. (2016). Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation. The American Journal of Human Genetics. 98(2). 339–346. 13 indexed citations

14.

Delpire, Eric, Lynne A. Wolfe, Rainelli Koumangoye, et al.. (2016). A patient with multisystem dysfunction carries a truncation mutation in human SLC12A2, the gene encoding the Na-K-2Cl cotransporter, NKCC1. Molecular Case Studies. 2(6). a001289–a001289. 41 indexed citations

15.

Mohammad, Saeed, Lynne A. Wolfe, Petra Stöbe, et al.. (2016). Infantile Cirrhosis, Growth Impairment, and Neurodevelopmental Anomalies Associated with Deficiency of PPP1R15B. The Journal of Pediatrics. 179. 144–149.e2. 8 indexed citations

16.

Parikh, Sumit, Amy Goldstein, Mary Kay Koenig, et al.. (2014). Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine. 17(9). 689–701. 372 indexed citations breakdown →

17.

Sincan, Murat, Thomas C. Markello, David R. Adams, et al.. (2014). The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. Genetics in Medicine. 16(10). 741–750. 49 indexed citations

18.

Goldstein, Amy & Lynne A. Wolfe. (2013). The Elusive Magic Pill: Finding Effective Therapies for Mitochondrial Disorders. Neurotherapeutics. 10(2). 320–328. 11 indexed citations

19.

He, Miao, Lisa E. Kratz, Joshua J. Michel, et al.. (2011). Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delay. Journal of Clinical Investigation. 121(3). 976–984. 82 indexed citations

20.

Wigglesworth, Mark, Lynne A. Wolfe, & Alan Wise. (2007). Orphan Seven Transmembrane Receptor Screening. PubMed. 105–144. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact